The Drug Controller General of India has issued a cautionary advisory to doctors and healthcare professionals regarding the discontinuation of Digene gel in the event of adverse drug reactions. This follows a complaint received by the DCGI about a batch of Digene gel produced by Abbott India in Goa, which had unusual characteristics.